Galenika® today represents the most modern version of a pharmaceutical manufacturer that has existed for nearly 80 years. From a small workshop that, as the fourth in the world, achieved independent penicillin production, to today’s digitally managed and controlled system, experts remain at the core of its success. Alongside technology, whose development mirrors the company’s own growth, it is these experts who have created the former Yugoslavia’s pharmaceutical giant, now regarded as one of the leading pharmaceutical companies in the region.

Operating as part of the Brazilian NC Group, which also includes EMS, the largest pharmaceutical company in Brazil and one of the largest in all of Latin America, Galenika® continues its expansion in the Western Balkans market and broadens its international influence on the global pharmaceutical scene, driven by the synergy of technology and world-class scientists. Nearly the entire product range is the result of in-house development.

In two manufacturing facilities—one for pharmaceuticals and one for solid pharmaceutical preparations—over 250 products are produced, including generic medicines, dietary supplements, cosmetic products, and medical devices, all developed in compliance with the highest certified GMP, ISO, and HACCP quality standards.